In order to evaluate during experimental Trypanosoma brucei infections the potential role of tumor necrosis factor alpha (TNF-␣) in the host-parasite interrelationship, C57BL/6 TNF-␣ knockout mice (TNF-␣ ؊/؊ ) as well as C57BL/6 wild-type mice were infected with pleomorphic T. brucei AnTat 1.1 E parasites. In the TNF-␣ ؊/؊ mice, the peak levels of parasitemia were strongly increased compared to the peak levels recorded in wild-type mice. The increased parasite burden did not reflect differences in clearance efficacy or in production of T. brucei-specific immunoglobulin M (IgM) and IgG antibodies. Trypanosome-mediated immunopathological features, such as lymph node-associated immunosuppression and lipopolysaccharide hypersensitivity, were found to be greatly reduced in infected TNF-␣ ؊/؊ mice. These results demonstrate that, during trypanosome infections, TNF-␣ is a key mediator involved in both parasitemia control and infection-associated pathology.
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African trypanosomes are extracellular parasitic protozoa transmitted by the bite of the tsetse fly (19) . In order to complete their life cycle, trypanosomes require an obligatory developmental step in a mammalian host. Consequently, these parasites have to cope with the host's immune system and establish a state of equilibrated growth regulation ensuring optimal survival and effective transmission. In the first place, African trypanosomes escape from immune recognition through the mechanism of antigenic variation of their variant-specific surface glycoproteins (VSG), the major surface antigen that acts as an ever-changing protective coat for the parasite (2, 15) . Besides this active VSG-based defense mechanism, Trypanosoma brucei parasites may utilize host immunoregulatory molecules to regulate their development. For instance, both epidermal growth factor (5) and gamma interferon (IFN-␥) (14) were reported to exert growth-enhancing properties on T. brucei parasites. In contrast, tumor necrosis factor alpha (TNF-␣) was documented (i) to be trypanolytic for T. brucei parasites in vitro (8, 10) and (ii) to reduce the parasite load in vivo (7, 9) . Hence, African trypanosomes may parasitize the host's cytokine network for their own benefit. However, chronic production of cytokines in turn influences the host in terms of immunopathology. In particular, the role of TNF-␣ in trypanosome-associated immunopathology was demonstrated in several studies documenting, for instance, (i) the enhanced expression of TNF-␣ mRNA in the brain of T. brucei-infected mice (6), (ii) the association between TNF-␣ production by monocytes and the severity of disease-associated anemia in trypanosome-infected cattle (17) , (iii) the correlation between serum TNF-␣ levels and the severity of neuropathological symptoms in human sleeping sickness (13) , and (iv) the involvement of TNF-␣ in trypanosome-elicited immunosuppression (3, 16) . Taken together, the accumulated knowledge about trypanosome-elicited production of TNF-␣ indicates that this cytokine exerts dual effects during trypanosome infections, influencing both the parasite and the host. As such, the induction of TNF-␣ production during T. brucei infections could be either beneficial or devastating for the host. It was thus of importance to use TNF-␣ knockout (TNF-␣ Ϫ/Ϫ ) mice (National Institute of Animal Health, Tsukuba City, Japan) (18) as a tool with which to reevaluate the role of TNF-␣ in the host-parasite interrelationship during trypanosome infections. The genes and gene expression for lymphotoxin-␣ and -␤, as well as the gene for FasL, all belonging to the TNF gene family, were shown to be unaffected by the gene disruption strategy used to obtain the TNF-␣ Ϫ/Ϫ mice (18) . To evaluate the influence of endogenous TNF-␣ on T. brucei parasitemia, C57BL/6 TNF-␣ Ϫ/Ϫ mice and C57BL/6 wild-type mice (all between 6 and 8 weeks of age) were infected intraperitoneally with 5,000 pleomorphic T. brucei AnTat 1.1 E parasites. Parasitemia in both TNF-␣ Ϫ/Ϫ and wild-type mice was monitored at intervals of 2 or 3 days by enumeration of the number of parasites present in the blood. As shown in Fig. 1 , TNF-␣ Ϫ/Ϫ mice exhibited significantly higher parasitemia peaks than did the wild-type mice. Despite these clear differences in peak levels, transient falls in parasitemia appear to occur at roughly the same time in TNF-␣ Ϫ/Ϫ and wild-type mice, indicating the presence of antiparasitic processes that are independent of TNF-␣ gene disruption. Since parasite clearance was documented to be antibody dependent (4), titers of antitrypanosome antibodies in serum were determined by enzyme-linked immunosorbent assay (ELISA) at different time points of infection (days 6, 7, 14, and 35). To this end, ELISA plates (Nunc, Roskilde, Denmark) were coated overnight with the flagellar pocket fraction (5 g/ml of phosphate-buffered saline [PBS]), prepared from T. brucei AnTat 1.1 parasites via density gradient centrifugation as described previously (12) . Subsequently, the plates were incubated with 1% bovine serum albumin-PBS for 1 h and incubated overnight with serial dilutions of sera isolated from naïve and T. brucei-infected TNF-␣ Ϫ/Ϫ and wild-type mice. Finally, plates were extensively washed and incubated with specific goat anti-mouse immunoglobulin M (IgM) (Promega, Madison, Wis.) or goat anti-mouse IgG (Sigma, St. Louis, Mo.) antibodies coupled to alkaline phosphatase. The ELISA was developed with 4-nitrophenyl phosphate substrate (Sigma), and the optical density at 450 nm (OD 450 ) was measured. Mean OD values (Ϯstandard deviation) were plotted as a function of the reciprocal serum dilutions used. The results shown in Fig. 2 indicate that TNF-␣ Ϫ/Ϫ mice and wild-type mice produce similar humoral antitrypanosome responses during an experimental T. brucei infection. In both strains of mice, the levels of IgM and IgG antitrypanosome antibodies increased significantly after the first peak of infection and remained high until the animals died.
Despite a significantly higher parasite load, the average survival times of T. brucei-infected TNF-␣ Ϫ/Ϫ mice and wild-type mice were not significantly different (Fig. 3) . Hereby it should be emphasized that, in TNF-␣ Ϫ/Ϫ mice, particularly during the late stage of infection, infection-related signs of morbidity were much less pronounced or even were absent compared to those in infected wild-type animals. The criteria used to quantify morbidity were lack of locomotor activity, anemia, and poor coat condition. The locomotor activity of control mice and T. brucei mice was recorded as the minutes per hour that the mice spent on spontaneous running around in the cage, eating, and drinking, as well as the time spent on cleaning their fur and nest. During the experimental setup, mice were kept in an animal facility with a regimen of 12 h of light and 12 h of dark per 24 h, starting with the first light cycle at 8 a.m. From day 8 postinfection, the time point that corresponded with the moment that numbers of parasites in the blood of both wild-type and TNF-␣ Ϫ/Ϫ mice dropped below detection limits, infected wild-type mice showed a severe reduction in locomotor activity. While noninfected mice normally have a long active period during the night and a short active period at the start of the light cycle (Fig. 4A) , the data recorded showed that infected wild-type mice sit most of the time immobilized and spend only a limited time eating and drinking (Fig. 4B) . The degree of impairment of locomotor activity of the infected wild-type mice persisted throughout the rest of the infection. In contrast to the infected wild-type mice, infected TNF-␣ Ϫ/Ϫ mice did not show any alterations in their locomotor activity on day 8 of the infection (Fig. 4C) . Also during later stages of infection, these mice showed no change in locomotor activity. Together with the impairment in activity, a sudden drop in the numbers of erythrocytes present in the blood of the infected wild-type mice was recorded by microscopical blood analysis. Within 48 h after the first transient drop in parasitemia, the numbers of erythrocytes had dropped to 58% Ϯ 12%. Anemia in the infected wild-type mice persisted throughout the rest of the infection, while no decrease in numbers of erythrocytes was recorded for the TNF-␣ Ϫ/Ϫ mice during the course of infection. The third parameter recorded to quantify trypanosomiasis-associated morbidity was the coat condition of the infected mice. Deterioration of the coat was observed in infected wildtype mice starting from day 8 postinfection, and a very poor coat condition was recorded toward the end of the infection (day 30), as shown in Fig. 5A . At the same stage of infection (day 30), no alterations in coat condition were observed in the infected TNF-␣ Ϫ/Ϫ mice (Fig. 5B) , although very high numbers of parasites were present in the blood of these mice (Fig. 1) .
The lack of morbidity prompted a comparative analysis of T. brucei-induced lipopolysaccharide (LPS) hypersensitivity, recorded 48 h later. Figure 6A shows that, in infected wild-type mice, an LPS dose as low as 0.5 g/mouse induced 100% mortality, while in noninfected controls, an LPS dose of 1 mg/mouse was needed to induce 100% mortality. In contrast, Fig. 6B shows that TNF-␣ Ϫ/Ϫ mice did not show any signs of LPS hypersensitivity upon infection with T. brucei parasites.
Trypanosome-associated immunosuppression is another immunopathological feature that occurs during experimental and natural infections with African trypanosomes. Here, TNF-␣ was reported to play a role in trypanosome-mediated induction of suppressive macrophages (3). In particular, during the chronic phase of the infection, lymph node-associated suppressive macrophages were documented to require both TNF-␣ (as an inducer of IFN-␥) and IFN-␥ (as an active mediator of suppressive activity). The involvement of TNF-␣ in T. brucei-elicited immunosuppression in the lymph nodes was thus reanalyzed in TNF-␣ Ϫ/Ϫ mice. Lymph node cells from T. brucei-infected wild-type or TNF-␣ Ϫ/Ϫ mice (LNCi), harvested during the chronic phase of infection (i.e., 35 days postinfection), were tested for their capacity to suppress the ex vivo concanavalin A (ConA)-induced blastogenesis of lymph node cells from noninfected wild-type mice (LNCn). Briefly, 2 ϫ 10 5 LNCi (TNF-␣ Ϫ/Ϫ or wild type) were cocultured with 2 ϫ 10 5 LNCn in 200 l of RPMI 1640 medium (GIBCO, Grand Island, N.Y.) supplemented with 10% fetal calf serum (Boehringer Pharma, Mannheim, Germany), 50 U of penicillin-streptomycin per ml, 300 g of L-glutamine per ml, and 5 ϫ 10 Ϫ5 M 2-mercaptoethanol. Cultures were stimulated with ConA (2.5 g/ml) at 37°C for 48 h in a humidified atmosphere containing 5% CO 2 . Indomethacin (Sigma) (10 g/ml) was added to all of the cultures in order to block any suppressive activity due to prostaglandins. Eighteen hours before harvesting, cultures were pulsed with 1 Ci of [ 3 H]thymidine, and incorporation of the labeled material into the newly synthesized DNA was determined and compared to the proliferative response of LNCn. Table 1 shows that while LNCi from wildtype mice completely inhibit T-cell responsiveness of LNCn to ConA, LNCi from TNF-␣ Ϫ/Ϫ mice exhibit no suppressive activity. Since the suppressive activity of T. brucei-elicited suppressive macrophages in lymph nodes was documented to rely on a nitric oxide (NO)-independent, IFN-␥-dependent mechanism (1), induction of both immunomodulators was quantified in cocultures of LNCi and LNCn activated with ConA (Table 1 ). Compared to cocultures of LNCn and LNCi from wild-type mice, the absence of suppressive activity in cocul- tures containing LNCi from TNF-␣ Ϫ/Ϫ mice was shown to be associated with (i) a slight but not significant decrease of NO production (quantified as nitrite accumulation by Griess reaction) and (ii) a partial, although significant, reduction of IFN-␥ secretion (P Ͻ 0.01), quantified by specific ELISA (Pharmingen, San Diego, Calif.). These data confirm previous results demonstrating than TNF-␣ contributes to the suppressive activity of LNCi via an upregulation of IFN-␥ and that NO produced by LNCi is not involved in the inhibition of ConAinduced proliferation of LNCn (1) . Furthermore, the fact that LNCi from TNF-␣ Ϫ/Ϫ mice still produce significantly higher levels of IFN-␥ compared to LNCn indicates that IFN-␥ may be required, yet is not sufficient, to cause suppressive activity, a finding that also is in agreement with previous results (3).
Collectively the results described herein point toward a crucial role of TNF-␣ during African trypanosome infections, influencing both the host and the parasite. Indeed, concerning the host, TNF-␣ participates in the apparent overall signs of morbidity as well as in immunopathological features of trypanosomiasis, such as LPS hypersensitivity and immunosuppressive activity in the lymph nodes. Of interest is the fact that, despite a reduction of immunopathology, the survival time of T. brucei-infected mice seems to be TNF-␣ independent. However, parasite development in T. brucei-infected TNF-␣ Ϫ/Ϫ mice reaches extremely high levels, corroborating the role of TNF-␣ in parasite control. It is possible that, during late-stage infections, the increased parasite burden is lethal to the host even in the absence of noxious cytokine side effects. Altogether, our results obtained with the present mouse model suggest that interference with TNF-␣ production during experimental African trypanosomiasis may be beneficial for both the host and parasite. Hence, the outcome of such intervention during natural T. brucei infections deserves further investigation. 
